ArticleJournal of experimental & clinical cancer research : CR2020

Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.

Haifang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.